Who We Are
PolyMedix is a clinical stage biotechnology company that is developing first-in-class, small-molecule drugs for the treatment of serious acute care conditions.
We are now on Twitter! Follow us to keep up with all the exciting new things coming to PolyMedix!follow us on twitter
Edward F. Smith, Interim President & CEO